TargetRx Atlas

mRNA_ID Gene Name drug_ID drug_Name Disease RNA_exp_pattern Evidence Details
ENST00000215659 MAPK12 NA SB202190 osteolytic prostate cancer down-regulated validated more...
ENST00000215659 MAPK12 DB11787 Ralimetinib osteolytic prostate cancer down-regulated validated more...
ENST00000215659 MAPK12 DB03044 Doramapimod osteolytic prostate cancer down-regulated validated more...
ENST00000229794 MAPK14 NA SB202190 osteolytic prostate cancer down-regulated validated more...
ENST00000229794 MAPK14 DB11787 Ralimetinib osteolytic prostate cancer down-regulated validated more...
ENST00000229794 MAPK14 DB03044 Doramapimod osteolytic prostate cancer down-regulated validated more...
ENST00000330651 MAPK11 NA SB202190 osteolytic prostate cancer down-regulated validated more...
ENST00000330651 MAPK11 DB11787 Ralimetinib osteolytic prostate cancer down-regulated validated more...
ENST00000330651 MAPK11 DB03044 Doramapimod osteolytic prostate cancer down-regulated validated more...
ENST00000373970 DKK1 NA SB202190 osteolytic prostate cancer down-regulated validated more...
ENST00000373970 DKK1 DB11787 Ralimetinib osteolytic prostate cancer down-regulated validated more...
ENST00000373970 DKK1 DB03044 Doramapimod osteolytic prostate cancer down-regulated validated more...